What is WuXi XDC Cayman Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. WuXi XDC Cayman's annualized net income for the quarter that ended in Jun. 2023 was HK$422 Mil. WuXi XDC Cayman's average shareholder tangible equity for the quarter that ended in Jun. 2023 was HK$1,531 Mil. Therefore, WuXi XDC Cayman's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2023 was 27.58%.
The historical rank and industry rank for WuXi XDC Cayman's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:02268'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.09 Med: 21.07 Max: 105.89
Current: 7.83
During the past 4 years, WuXi XDC Cayman's highest Return-on-Tangible-Equity was 105.89%. The lowest was 7.09%. And the median was 21.07%.
HKSE:02268's Return-on-Tangible-Equity is ranked better than 64.82% of 199
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.81
vs HKSE:02268: 7.83
WuXi XDC Cayman Return-on-Tangible-Equity Historical Data
The historical data trend for WuXi XDC Cayman's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of WuXi XDC Cayman's Return-on-Tangible-Equity
For the Diagnostics & Research subindustry, WuXi XDC Cayman's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WuXi XDC Cayman's Return-on-Tangible-Equity Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where WuXi XDC Cayman's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2023) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
WuXi XDC Cayman Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of WuXi XDC Cayman's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02268 has been successfully added to your